Daiken Medical Co Ltd
TSE:7775
Intrinsic Value
Daiken Medical Co., Ltd. engages in the planning, development, production, and sale of anesthesia and infection control products. [ Read More ]
The intrinsic value of one Daiken Medical Co Ltd stock under the Base Case scenario is 823.34 JPY. Compared to the current market price of 556 JPY, Daiken Medical Co Ltd is Undervalued by 32%.
Valuation Backtest
Daiken Medical Co Ltd
Run backtest to discover the historical profit from buying and selling Daiken Medical Co Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Daiken Medical Co Ltd
| Current Assets | 6.8B |
| Cash & Short-Term Investments | 2.5B |
| Receivables | 2.7B |
| Other Current Assets | 1.6B |
| Non-Current Assets | 4.3B |
| PP&E | 4B |
| Intangibles | 14.3m |
| Other Non-Current Assets | 300.6m |
| Current Liabilities | 3.5B |
| Accounts Payable | 1.1B |
| Accrued Liabilities | 81.5m |
| Short-Term Debt | 1.4B |
| Other Current Liabilities | 930.2m |
| Non-Current Liabilities | 730.4m |
| Long-Term Debt | 708.4m |
| Other Non-Current Liabilities | 22m |
Earnings Waterfall
Daiken Medical Co Ltd
|
Revenue
|
9.6B
JPY
|
|
Cost of Revenue
|
-5.9B
JPY
|
|
Gross Profit
|
3.8B
JPY
|
|
Operating Expenses
|
-2.4B
JPY
|
|
Operating Income
|
1.3B
JPY
|
|
Other Expenses
|
-410.1m
JPY
|
|
Net Income
|
912.1m
JPY
|
Free Cash Flow Analysis
Daiken Medical Co Ltd
Profitability Score
Profitability Due Diligence
Daiken Medical Co Ltd's profitability score is 56/100. The higher the profitability score, the more profitable the company is.
Score
Daiken Medical Co Ltd's profitability score is 56/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Daiken Medical Co Ltd's solvency score is 82/100. The higher the solvency score, the more solvent the company is.
Score
Daiken Medical Co Ltd's solvency score is 82/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Daiken Medical Co Ltd
According to Wall Street analysts, the average 1-year price target for Daiken Medical Co Ltd is 900 JPY .
Shareholder Return
Price
Daiken Medical Co Ltd
| Average Annual Return | -1.91% |
| Standard Deviation of Annual Returns | 16% |
| Max Drawdown | -39% |
| Market Capitalization | 16B JPY |
| Shares Outstanding | 28 728 400 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Daiken Medical Co., Ltd. engages in the planning, development, production, and sale of anesthesia and infection control products. The company is headquartered in Izumi-Shi, Osaka-Fu and currently employs 186 full-time employees. The company went IPO on 2009-03-12. The Company’s products are divided into five groups. The suction device related products include Fit Fix suction container system and Coopdech QinPot. The syrinjector related products include syrinjector, balloonjector, patient control analgesia (PCA) devices and other pressure infusion instruments. The electric pump related products include syringe pumps and infusion pumps. The medical hand washing machine related products include SteriKeep II and Wipell. The other products include bronchial blocker tube, breath warm and others.
Contact
IPO
Employees
Officers
The intrinsic value of one Daiken Medical Co Ltd stock under the Base Case scenario is 823.34 JPY.
Compared to the current market price of 556 JPY, Daiken Medical Co Ltd is Undervalued by 32%.
You don't have any saved screeners yet
